[HTML][HTML] Physiologically-based pharmacokinetic models for children: Starting to reach maturation?
LFM Verscheijden, JB Koenderink, TN Johnson… - Pharmacology & …, 2020 - Elsevier
Developmental changes in children can affect the disposition and clinical effects of a drug,
indicating that scaling an adult dose simply down per linear weight can potentially lead to …
indicating that scaling an adult dose simply down per linear weight can potentially lead to …
Caffeine for the pharmacological treatment of apnea of prematurity in the NICU: dose selection conundrum, therapeutic drug monitoring and genetic factors
JY Long, HL Guo, X He, YH Hu, Y Xia… - Frontiers in …, 2021 - frontiersin.org
Caffeine citrate is the drug of choice for the pharmacological treatment of apnea of
prematurity. Factors such as maturity and genetic variation contribute to the interindividual …
prematurity. Factors such as maturity and genetic variation contribute to the interindividual …
Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of …
K Abduljalil, A Pansari, M Jamei - Journal of pharmacokinetics and …, 2020 - Springer
Concerns over gestational effects on the disposition of drugs has highlighted the need for a
better understanding of drug distribution and elimination during pregnancy. This study …
better understanding of drug distribution and elimination during pregnancy. This study …
[HTML][HTML] Application of a physiologically based pharmacokinetic approach to predict theophylline pharmacokinetics using virtual non-pregnant, pregnant, fetal, breast …
K Abduljalil, I Gardner, M Jamei - Frontiers in Pediatrics, 2022 - frontiersin.org
Perinatal pharmacology is influenced by a myriad of physiological variables that are
changing dynamically. The influence of these covariates has not been assessed …
changing dynamically. The influence of these covariates has not been assessed …
Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK
H Zazo, E Lagarejos, M Prado-Velasco… - Frontiers in …, 2022 - frontiersin.org
Each year, infections caused around the 25% of neonatal deaths. Early empirical treatments
help to reduce this mortality, although optimized dosing regimens are still lacking. The aims …
help to reduce this mortality, although optimized dosing regimens are still lacking. The aims …
A preterm physiologically based pharmacokinetic model. Part I: physiological parameters and model building
K Abduljalil, X Pan, A Pansari, M Jamei… - Clinical …, 2020 - Springer
Background Developmental physiology can alter pharmacotherapy in preterm populations.
Because of ethical and clinical constraints in studying this vulnerable age group …
Because of ethical and clinical constraints in studying this vulnerable age group …
Physiologically based pharmacokinetic (PBPK) model-informed dosing guidelines for pediatric clinical care: a pragmatic approach for a special population
JJM Freriksen, JEM van der Heijden… - Pediatric Drugs, 2023 - Springer
Physiologically based pharmacokinetic (PBPK) modeling can be an attractive tool to
increase the evidence base of pediatric drug dosing recommendations by making optimal …
increase the evidence base of pediatric drug dosing recommendations by making optimal …
The analysis of pethidine pharmacokinetics in newborn saliva, plasma, and brain extracellular fluid after prenatal intrauterine exposure from pregnant mothers …
MM Alsmadi, N Idkaidek - European Journal of Drug Metabolism and …, 2023 - Springer
Abstract Background and Objective Pethidine (meperidine) can decrease labor pain-
associated mother's hyperventilation and high cortisol-induced newborn complications …
associated mother's hyperventilation and high cortisol-induced newborn complications …
Use of antibiotics in preterm newborns
R Simeoli, S Cairoli, N Decembrino, F Campi… - Antibiotics, 2022 - mdpi.com
Due to complex maturational and physiological changes that characterize neonates and
affect their response to pharmacological treatments, neonatal pharmacology is different from …
affect their response to pharmacological treatments, neonatal pharmacology is different from …
Considerations for drug dosing in premature infants
J van den Anker, K Allegaert - The Journal of Clinical …, 2021 - Wiley Online Library
In premature infants, effective and safe drug therapy depends on optimal dose selection and
requires a thorough understanding of the underlying disease (s) of these fragile infants as …
requires a thorough understanding of the underlying disease (s) of these fragile infants as …